Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Vaccine|January 11, 2011
Quantitative assessment of masking of neutralization epitopes in HIV-1Alpna Agarwal, Catarina E Hioe, James Swetnam, et al.AIDS Research and Human Retroviruses|March 22, 2017
Short Communication: Manα1-2Man-Binding Anti-HIV Lectins Enhance the Exposure of V2i and V3 Crown Neutralization Epitopes on the V1/V2 and V3 Hypervariable Loops of HIV-1 EnvelopeMuzafar Jan, Chitra Upadhyay, Aman Sharma, et al.Journal of Virology|August 28, 2009
Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapseGaia Vasiliver-Shamis, Michael W Cho, Catarina E Hioe, et al.Plos One|March 27, 2018
Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectinsMuzafar Jan, Chitra Upadhyay, José Alcami Pertejo, et al.Statistics in Biopharmaceutical Research|March 25, 2014
Statistical approaches to analyzing HIV-1 neutralizing antibody assay dataXuesong Yu, Peter B Gilbert, Catarina E Hioe, et al.Plos Pathogens|January 26, 2018
Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutationsChitra Upadhyay, Roya Feyznezhad, Weiming Yang, et al.Journal of the American Society for Mass Spectrometry|August 1, 2006
The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometryJason G Williams, Kenneth B Tomer, Catarina E Hioe, et al.Vaccine|September 21, 2013
Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccinesRajnish Kumar, Michael Tuen, Jianping Liu, et al.Journal of Visualized Experiments : Jove|March 22, 2012
Imaging of HIV-1 envelope-induced virological synapse and signaling on synthetic lipid bilayersKathleen C Prins, Gaia Vasiliver-Shamis, Michael Cammer, et al.Journal of Virology|June 29, 2004
Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processingPeter C Chien, Sandra Cohen, Michael Tuen, et al.Pageof 7